Video presentation and panel debate at BioStock Life Science Summit 2018

Our CEO Johan Ny recently presented the 2018 Öresund Investor Climate Report at the BioStock Life Science Summit at Medicon Village in Lund in October. The event was popular and approximately 10 000 investors tuned in via web casting.

The presentation was followed by a panel debate on the future of early stage life science investing in the Nordics. The panel was moderated by Jonas Sjöqvist editor in chief at BIoStock; the other panel members consisted of two CEOs from early stage life science companies - Johan Bjurqvist from Liv Diagnostics and Ole Thestrup from 2CureX as well as Fredrik Rahl from the Corporate finance adviser Sedermera Fondkommission.

The panel concluded that Nordic early stage life science companies have great scientific results, but must secure a commercial plan in both short and long term perspective - regardless if they are privately held or listed at NasdaqFirst North or Spotlight.

Learn more about the companies included:


Liv Diagnostics:


Sedermera Fondkommission: